Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block for Pediatric Scoliosis Surgery
NCT05944393Unknown
- Sponsor
- Poznan University of Medical Sciences
- Start
- Sep 2022
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in scoliosis (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Pain Score at 48 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
scoliosis
Beyond the preview
Go deeper on NCT05944393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944393.